
    
      Subjects who completed all dosing visits and the post treatment challenge (PTC) in study
      TG002 will be invited to attend the Screening Visit for TG002a. Subjects will attend for 4
      visits to the EEU on successive days. Following the last EEC visit a follow-up visit will be
      performed 3-10 days later.
    
  